FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14311311000001103: Gliclazide 30mg modified-release tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50671101000001110 Gliclazide 30mg modified-release tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
50671201000001115 Gliclazide 30mg modified-release tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 30mg modified-release tablets 30 tablet Has VMP Gliclazide 30mg modified-release tablets true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Is pack of Gliclazide 30mg m/r tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Has active ingredient Gliclazide false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Has VMP Gliclazide 30mg m/r tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 30 tablet Has VMP Gliclazide 30mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Diamicron 30mg MR tablets (Sigma Pharmaceuticals Plc) 30 tablet Is a True Gliclazide 30mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start